Eribulin-induced radiation recall dermatitis: a case report and brief review of the literature.

Ecancermedicalscience · 2020 · PMC7039694 · PMID 32104208

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.056so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

A second study [ 12 ] compared Eribulin against capecitabine in 1102 patients and showed a trend towards better OS: 15.9 months in Eribulin versus 14.5 in control; however, this difference did not reach statistical significance ( p = 0.056).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.